Because of the importance of cytokine control of the inflammatory microenvironment favoring or inhibiting tumor progression [48], [61], we investigated the level of IL-6, IL-8 and MCP-1 released by Hep-2 cells. The gene discussed is CCL2; the disease is neoplasm.